tiprankstipranks
Hinge Health, Inc. Class A (HNGE)
NYSE:HNGE
US Market
HNGE
Hinge Health, Inc. Class A
RESEARCH TOOLSreports
Want to see HNGE full AI Analyst Report?

Hinge Health, Inc. Class A (HNGE) Stock Forecast & Price Target

188 Followers
See the Price Targets and Ratings of:

HNGE Analyst Ratings

Strong Buy
15Ratings
Strong Buy
14 Buy
1 Hold
0 Sell
Based on 15 analysts giving stock ratings to
Hinge
Health, Inc. Class A
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HNGE Stock 12 Month Forecast

Average Price Target

$77.00
▲(77.75% Upside)
Based on 15 Wall Street analysts offering 12 month price targets for Hinge Health, Inc. Class A in the last 3 months. The average price target is $77.00 with a high forecast of $95.00 and a low forecast of $45.00. The average price target represents a 77.75% change from the last price of $43.32.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"34":"$34","65":"$65","96":"$96","49.5":"$49.5","80.5":"$80.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$95.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$77.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$45.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[34,49.5,65,80.5,96],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.92,63.541538461538465,66.16307692307693,68.78461538461539,71.40615384615384,74.0276923076923,76.64923076923077,79.27076923076923,81.8923076923077,84.51384615384615,87.13538461538462,89.75692307692307,92.37846153846154,{"y":95,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.92,62.15692307692308,63.393846153846155,64.63076923076923,65.86769230769231,67.10461538461539,68.34153846153846,69.57846153846154,70.81538461538462,72.05230769230769,73.28923076923077,74.52615384615385,75.76307692307692,{"y":77,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,60.92,59.69538461538462,58.470769230769235,57.246153846153845,56.02153846153846,54.79692307692308,53.572307692307696,52.34769230769231,51.12307692307692,49.89846153846154,48.673846153846156,47.449230769230766,46.22461538461539,{"y":45,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":40.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.68,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":46.45,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.86,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.49,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.43,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.92,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$95.00Average Price Target$77.00Lowest Price Target$45.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on HNGE
Stan Berenshteyn
Wells Fargo
Wells Fargo
$80→$90
Buy
107.76%
Upside
Assigned
06/23/26
Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)
Robert W. Baird Analyst forecast on HNGE
Vikram Kesavabhotla
Robert W. Baird
Robert W. Baird
$55→$65
Hold
50.05%
Upside
Reiterated
06/17/26
Hinge Health price target raised to $65 from $55 at BairdHinge Health price target raised to $65 from $55 at Baird
Canaccord Genuity Analyst forecast on HNGE
Richard Close
Canaccord Genuity
Canaccord Genuity
$65→$76
Buy
75.44%
Upside
Assigned
06/15/26
Hinge Health price target raised to $76 from $65 at CanaccordHinge Health price target raised to $76 from $65 at Canaccord
Raymond James Analyst forecast on HNGE
Brian Peterson
Raymond James
Raymond James
$70→$80
Buy
84.67%
Upside
Reiterated
06/15/26
Hinge Health price target raised to $80 from $70 at Raymond JamesHinge Health price target raised to $80 from $70 at Raymond James
KeyBanc Analyst forecast on HNGE
Scott Schoenhaus
KeyBanc
KeyBanc
$75→$90
Buy
107.76%
Upside
Assigned
06/12/26
Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV)
Barclays Analyst forecast on HNGE
Saket Kalia
Barclays
Barclays
$62→$70
Buy
61.59%
Upside
Assigned
06/11/26
Barclays Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Morgan Stanley Analyst forecast on HNGE
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$72
Buy
66.20%
Upside
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM) and Hinge Health, Inc. Class A (NYSE: HNGE)
William Blair Analyst forecast on HNGE
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP) and Hinge Health, Inc. Class A (NYSE: HNGE)
Stifel Nicolaus Analyst forecast on HNGE
David Grossman
Stifel Nicolaus
Stifel Nicolaus
$79
Buy
82.36%
Upside
Assigned
06/11/26
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (NASDAQ: GPCR), Cabaletta Bio (NASDAQ: CABA) and Hinge Health, Inc. Class A (NYSE: HNGE)
Truist Financial Analyst forecast on HNGE
Jailendra Singh
Truist Financial
Truist Financial
$79→$85
Buy
96.21%
Upside
Reiterated
06/11/26
Truist Financial Sticks to Their Buy Rating for Hinge Health, Inc. Class A (HNGE)
Needham Analyst forecast on HNGE
Ryan MacDonald
Needham
Needham
$76
Buy
75.44%
Upside
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Hinge Health, Inc. Class A (NYSE: HNGE)
RBC Capital Analyst forecast on HNGE
Rishi Jaluria
RBC Capital
RBC Capital
$65→$75
Buy
73.13%
Upside
Reiterated
06/10/26
RBC Capital Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Citizens JMP Analyst forecast on HNGE
Aaron Kimson
Citizens JMP
Citizens JMP
$65→$80
Buy
84.67%
Upside
Reiterated
05/06/26
Hinge Health price target raised to $80 from $65 at CitizensHinge Health price target raised to $80 from $65 at Citizens
Piper Sandler Analyst forecast on HNGE
Jessica Tassan
Piper Sandler
Piper Sandler
$60→$95
Buy
119.30%
Upside
Reiterated
05/06/26
Hinge Health price target raised to $95 from $60 at Piper SandlerHinge Health price target raised to $95 from $60 at Piper Sandler
Evercore ISI Analyst forecast on HNGE
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$45
Buy
3.88%
Upside
Reiterated
04/30/26
Evercore ISI Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on HNGE
Stan Berenshteyn
Wells Fargo
Wells Fargo
$80→$90
Buy
107.76%
Upside
Assigned
06/23/26
Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)
Robert W. Baird Analyst forecast on HNGE
Vikram Kesavabhotla
Robert W. Baird
Robert W. Baird
$55→$65
Hold
50.05%
Upside
Reiterated
06/17/26
Hinge Health price target raised to $65 from $55 at BairdHinge Health price target raised to $65 from $55 at Baird
Canaccord Genuity Analyst forecast on HNGE
Richard Close
Canaccord Genuity
Canaccord Genuity
$65→$76
Buy
75.44%
Upside
Assigned
06/15/26
Hinge Health price target raised to $76 from $65 at CanaccordHinge Health price target raised to $76 from $65 at Canaccord
Raymond James Analyst forecast on HNGE
Brian Peterson
Raymond James
Raymond James
$70→$80
Buy
84.67%
Upside
Reiterated
06/15/26
Hinge Health price target raised to $80 from $70 at Raymond JamesHinge Health price target raised to $80 from $70 at Raymond James
KeyBanc Analyst forecast on HNGE
Scott Schoenhaus
KeyBanc
KeyBanc
$75→$90
Buy
107.76%
Upside
Assigned
06/12/26
Analysts Are Bullish on These Healthcare Stocks: C4 Therapeutics (CCCC), AbbVie (ABBV)
Barclays Analyst forecast on HNGE
Saket Kalia
Barclays
Barclays
$62→$70
Buy
61.59%
Upside
Assigned
06/11/26
Barclays Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Morgan Stanley Analyst forecast on HNGE
Craig Hettenbach
Morgan Stanley
Morgan Stanley
$72
Buy
66.20%
Upside
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (NASDAQ: MIRM) and Hinge Health, Inc. Class A (NYSE: HNGE)
William Blair Analyst forecast on HNGE
Ryan Daniels
William Blair
William Blair
―
Buy
―
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (NASDAQ: CRSP) and Hinge Health, Inc. Class A (NYSE: HNGE)
Stifel Nicolaus Analyst forecast on HNGE
David Grossman
Stifel Nicolaus
Stifel Nicolaus
$79
Buy
82.36%
Upside
Assigned
06/11/26
Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (NASDAQ: GPCR), Cabaletta Bio (NASDAQ: CABA) and Hinge Health, Inc. Class A (NYSE: HNGE)
Truist Financial Analyst forecast on HNGE
Jailendra Singh
Truist Financial
Truist Financial
$79→$85
Buy
96.21%
Upside
Reiterated
06/11/26
Truist Financial Sticks to Their Buy Rating for Hinge Health, Inc. Class A (HNGE)
Needham Analyst forecast on HNGE
Ryan MacDonald
Needham
Needham
$76
Buy
75.44%
Upside
Reiterated
06/11/26
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (NASDAQ: SION) and Hinge Health, Inc. Class A (NYSE: HNGE)
RBC Capital Analyst forecast on HNGE
Rishi Jaluria
RBC Capital
RBC Capital
$65→$75
Buy
73.13%
Upside
Reiterated
06/10/26
RBC Capital Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Citizens JMP Analyst forecast on HNGE
Aaron Kimson
Citizens JMP
Citizens JMP
$65→$80
Buy
84.67%
Upside
Reiterated
05/06/26
Hinge Health price target raised to $80 from $65 at CitizensHinge Health price target raised to $80 from $65 at Citizens
Piper Sandler Analyst forecast on HNGE
Jessica Tassan
Piper Sandler
Piper Sandler
$60→$95
Buy
119.30%
Upside
Reiterated
05/06/26
Hinge Health price target raised to $95 from $60 at Piper SandlerHinge Health price target raised to $95 from $60 at Piper Sandler
Evercore ISI Analyst forecast on HNGE
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$45
Buy
3.88%
Upside
Reiterated
04/30/26
Evercore ISI Keeps Their Buy Rating on Hinge Health, Inc. Class A (HNGE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Hinge Health, Inc. Class A

3 Months
Saket KaliaBarclays
Success Rate
7/9 ratings generated profit
78%
Average Return
+22.22%
Copying Saket Kalia's trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +22.22% per trade.
1 Year
Elizabeth Anderson CFAEvercore ISI
Success Rate
7/7 ratings generated profit
100%
Average Return
+56.56%
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +56.56% per trade.
2 Years
Elizabeth Anderson CFAEvercore ISI
Success Rate
7/7 ratings generated profit
100%
Average Return
+56.26%
Copying Elizabeth Anderson CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.26% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HNGE Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
9
10
11
5
4
Buy
22
23
18
23
36
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
33
29
28
41
In the current month, HNGE has received 40 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HNGE average Analyst price target in the past 3 months is 77.00.
Each month's total comprises the sum of three months' worth of ratings.

HNGE Financial Forecast

HNGE Earnings Forecast

Next quarter’s earnings estimate for HNGE is $0.61 with a range of $0.47 to $0.70. The previous quarter’s EPS was $0.45. HNGE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.
Next quarter’s earnings estimate for HNGE is $0.61 with a range of $0.47 to $0.70. The previous quarter’s EPS was $0.45. HNGE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.

HNGE Sales Forecast

Next quarter’s sales forecast for HNGE is $199.41M with a range of $179.00M to $203.10M. The previous quarter’s sales results were $182.31M. HNGE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.
Next quarter’s sales forecast for HNGE is $199.41M with a range of $179.00M to $203.10M. The previous quarter’s sales results were $182.31M. HNGE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HNGE has Performed in-line its overall industry.

HNGE Stock Forecast FAQ

What is HNGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Hinge Health, Inc. Class A’s 12-month average price target is 77.00.
    What is HNGE’s upside potential, based on the analysts’ average price target?
    Hinge Health, Inc. Class A has 77.75% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HNGE a Buy, Sell or Hold?
          Hinge Health, Inc. Class A has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Hinge Health, Inc. Class A’s price target?
            The average price target for Hinge Health, Inc. Class A is 77.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $95.00 ,the lowest forecast is $45.00. The average price target represents 77.75% Increase from the current price of $43.32.
              What do analysts say about Hinge Health, Inc. Class A?
              Hinge Health, Inc. Class A’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
                How can I buy shares of HNGE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.